Iridium
US-FDASourced from openFDA
GET
/api/v1/drug/iridiumIndications
Sourced from openFDA- May temporarily relieve symptoms associated with industrial pollutants, such as cough, sensation of looseness in chest, rhinitis, and hoarseness with rough scraped feeling in the throat.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.ICD-10: R05.9
Dosage & administration
Sourced from openFDADIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAIf pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
1 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Cardiac Flutter1100%
- 2Heart Rate Increased1100%
- 3Palpitations1100%
- 4Product Substitution Issue1100%
- 5Supraventricular Extrasystoles1100%
- 6Ventricular Extrasystoles1100%
- 7Wrong Technique In Drug Usage Process1100%
Literature
Recent PubMed references pinned to Iridium as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- DNA-Binding Properties of Iridium(III) Complexes Encompassing Design, Function and Biophysical Assessments.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026 · Alkhaibari IS, Buurma NJ, Pope SJA, et al.PMID 42248606DOI 10.1002/cphc.70426
- Smartphone-based fluorescence imaging combined with a convolutional neural network-assisted intelligent multichannel immunosensor for simultaneous identification of four Salmonella serotypes based on multicolor luminescent iridium complexes.Analytica chimica acta · 2026 · Ke L, Liu X, Gu M, et al.PMID 42242803DOI 10.1016/j.aca.2026.345720
- Ir(III) complexes for photo-activated mitochondrial G-quadruplex damage against cisplatin-resistant cancer cells.Journal of inorganic biochemistry · 2026 · Huang S, Yang J, Xiong K, et al.PMID 42143975DOI 10.1016/j.jinorgbio.2026.113364
- Organometallic Iridium(III) complex interacts with DNA and exhibits anticancer potential: Insights from biophysical, cell-based and computational studies.Biochemical and biophysical research communications · 2026 · Chakraborty D, Behera S, Naik N, et al.PMID 42143443DOI 10.1016/j.bbrc.2026.153920
- Targeted liposome entrapped iridium(III) complexes significantly increase antitumor activity in vitro and in vivo.European journal of medicinal chemistry · 2026 · Nie H, Xiang J, Wang N, et al.PMID 42140112DOI 10.1016/j.ejmech.2026.118948
- Attack of NADH and ascorbate toward metal-activated ligand of organoiridium(III) compound.Journal of inorganic biochemistry · 2026 · Štarha P, Řezníčková E, Šterbinská S, et al.PMID 42133998DOI 10.1016/j.jinorgbio.2026.113343
- Label-Free Electrochemiluminescence Detection of Urinary AD7c-NTP Using Structurally Optimized Iridium(III) Complexes on Boron-Doped Diamond Electrodes.Analytical chemistry · 2026 · Wang T, Zhou Y, Wang B, et al.PMID 42126049DOI 10.1021/acs.analchem.6c00503
- A Signal-Amplified Electrochemiluminescent Biosensor Based on Iridium Nanocluster Synergies with a Bipedal DNA Walker for CYFRA21-1 Detection.Analytical chemistry · 2026 · Wang J, Du Y, Zhang X, et al.PMID 42068553DOI 10.1021/acs.analchem.6c00973
Clinical trials
The 10 most recently updated of 17 ClinicalTrials.gov registrations naming Iridium as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive TherapyTerminated · Interventional · 65 enrolled · Fidia Farmaceutici s.p.a.NCT06190028updated 2026-02-25
- Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant TreatmentRecruiting · Interventional · 80 enrolled · Fidia Farmaceutici s.p.a.NCT07431385updated 2026-02-24
- Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate CancerRecruiting · Observational · 100 enrolled · British Columbia Cancer AgencyNCT06200974updated 2026-02-02
- LDR vs. HDR Brachytherapy for Prostate CancerActive not recruiting · Interventional · 140 enrolled · British Columbia Cancer AgencyNCT03426748updated 2026-01-29
- A Clinical Study on the Use of a Domestically Produced Three-dimensional Cardiac Electrophysiological Mapping System Combined With Pressure Monitoring Technology and Star Mapping Technology for the Treatment of Paroxysmal Atrial Fibrillation.Not yet recruiting · Interventional · 20 enrolled · Shanghai MicroPort EP MedTech Co., Ltd.NCT07039032updated 2025-06-27
- Sensory Motor Transformations in Human CortexRecruiting · Interventional · 5 enrolled · Richard A. Andersen, PhDNCT01964261updated 2025-05-22
- Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate CancerActive not recruiting · Phase 3 · Interventional · 60 enrolled · British Columbia Cancer AgencyNCT02692105updated 2025-03-13
- Planned Non-operative Management for Rectal CancerUnknown · Phase 2 · Interventional · 23 enrolled · Maria Sklodowska-Curie National Research Institute of OncologyNCT05241574updated 2022-02-15
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & SurgeryUnknown · Phase 2 · Interventional · 60 enrolled · The Methodist Hospital Research InstituteNCT03541928updated 2021-04-06
- Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract SymptomsCompleted · Interventional · 100 enrolled · Hospital Universitario de FuenlabradaNCT03936244updated 2020-11-12
Frequently asked questions
- What is Iridium used for?
- According to FDA labeling, Iridium carries indications including: May temporarily relieve symptoms associated with industrial pollutants, such as cough, sensation of looseness in chest, rhinitis, and hoarseness with rough scraped feeling in the throat.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for
iridium is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.